TRIFLUOPERAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS
Adverse effects/events: at least 1 adverse effect ‐ as defined by individual studies. · patients with schizophrenia
Trifluoperazine showed no clear difference in adverse events: 1. General ‐ at least one adverse effect compared with low‐potency antipsychotic drugs (moderate certainty).
1 finding from 1 review
- Trifluoperazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes onlyRR 1.6 [0.94, 2.74]1 study · 60 participantsModerate